Brainstorm cell therapeutics announces first quarter 2025 financial results and provides corporate update

Conference call and webcast rescheduled for 8:30 a.m. eastern time on monday, may 19 new york , may 15, 2025 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the first quarter ended march 31, 2025, and provided a corporate update.
BCLI Ratings Summary
BCLI Quant Ranking